ID
14835
Description
Bendamustine Versus Fludarabine in Chronic Lymphocytic Leukemia (CLL); ODM derived from: https://clinicaltrials.gov/show/NCT01423032
Link
https://clinicaltrials.gov/show/NCT01423032
Keywords
Versions (1)
- 5/1/16 5/1/16 -
Uploaded on
May 1, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Chronic Lymphocytic Leukemia NCT01423032
Eligibility Chronic Lymphocytic Leukemia NCT01423032
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
ID.6
Data type
boolean
Description
ID.7
Data type
boolean
Alias
- UMLS CUI [1]
- C0349631
Description
ID.8
Data type
boolean
Alias
- UMLS CUI [1]
- C0059985
- UMLS CUI [2]
- C0525079
Description
ID.9
Data type
boolean
Alias
- UMLS CUI [1]
- C0275518
- UMLS CUI [2]
- C0025517
- UMLS CUI [3]
- C0678852
Description
ID.10
Data type
boolean
Alias
- UMLS CUI [1]
- C3266877
Similar models
Eligibility Chronic Lymphocytic Leukemia NCT01423032
- StudyEvent: Eligibility
C0019638 (UMLS CUI [1,2])
C0277556 (UMLS CUI [2])
C1514715 (UMLS CUI [2])
C0700589 (UMLS CUI [2])
C0525079 (UMLS CUI [2])
C0025517 (UMLS CUI [2])
C0678852 (UMLS CUI [3])